AI Bias Analysis
4 models · Takes ~15 seconds
The firm says it can can reduce the cost of chip development by more than 75% and cut the timeline by more than half.
Source
TechCrunch
Opens original article in a new tab
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Confidential SEC submission sets up largest IPO in history.
Meta's upcoming Hyperion AI data center will be powered by 10 new natural gas plants.
A new study from researchers at UC Berkeley and UC Santa Cruz suggests models will disobey human commands to protect their own kind.